Merck & Co. logo
Merck & Co. MRK
$ 112.16 2.81%

Annual report 2025
added 02-24-2026

report update icon

Merck & Co. Gross Profit 2011-2026 | MRK

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Merck & Co.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - - - 32.7 B 28.8 B 27.3 B 25.9 B 24.6 B 25.5 B 27.1 B 30.8 B 31.2 B

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
32.7 B 24.6 B 28.2 B

Gross Profit of other stocks in the Biotechnology industry

Issuer Gross Profit Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
180 M - 2.43 % $ 254 M germanyGermany
AgeX Therapeutics AgeX Therapeutics
AGE
102 K - -10.17 % $ 12.2 K usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-428 K - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.52 B - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
5.51 M - 2.54 % $ 160 B franceFrance
Cerus Corporation Cerus Corporation
CERS
60.4 M $ 2.72 33.99 % $ 518 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
473 M $ 21.95 -2.23 % $ 3.64 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
12.1 - -1.52 % $ 24.7 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
90 K - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
48.1 B - - $ 96.9 B britainBritain
Berkeley Lights Berkeley Lights
BLI
53.8 M - -7.31 % $ 87 M usaUSA
Advaxis Advaxis
ADXS
90 K - -9.65 % $ 45.9 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
64.9 M - - $ 3.74 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
774 M - - - russiaRussia
Cardiff Oncology Cardiff Oncology
CRDF
245 K $ 1.71 -1.16 % $ 114 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
4.15 M - -16.75 % $ 25.8 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
2.65 M - 5.93 % $ 314 M canadaCanada
AIkido Pharma AIkido Pharma
AIKI
10 K - 1.93 % $ 17.4 M usaUSA
Editas Medicine Editas Medicine
EDIT
1.63 M $ 2.9 -3.33 % $ 257 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
15.8 M - - $ 2.02 B usaUSA
Edesa Biotech Edesa Biotech
EDSA
311 K $ 17.59 -3.75 % $ 56.2 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.03 M $ 2.93 -8.15 % $ 4.82 M israelIsrael
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
200 K - -5.68 % $ 8.28 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
-10.6 M - - $ 867 M germanyGermany
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-523 K - -11.43 % $ 502 K usaUSA
Aptinyx Aptinyx
APTX
1.56 K - -39.0 % $ 4.57 M usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
-241 K $ 0.81 3.33 % $ 27.9 M israelIsrael
Aravive Aravive
ARAV
5.68 K - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
1 K - 17.91 % $ 11.1 M usaUSA